Microbial Robotics is a global biotechnology firm. We rapidly prototype synthetic biology-based bacterial (BactoBots) and viral (ViruBots) technologies. These MicrobialBots products are provided to industrial customers. The MicrobialBots can perform functions such as bio-marker detection, kill cancer cells, produce chemicals or build materials, and can add value for the water, chemical, and pharmaceutical industries.
Our Open Therapeutics model and the Global SynBio network of scientists and industry professionals collaborate on open commercialization efforts to develop chemical, therapeutic, and water applications.
Proteome Antibiotics™ is a joint effort with Bacmine SL to develop an antibiotic discovery platform against pathogens including methicillin-resistant MRSA and multi-drug resistant tuberculosis (MDR-TB).
GeRM™ (patent pending) provides a competitive advantage in synthetic biology through enabling collaborative partnerships and recurring revenue models.